Supplementary Table 1 from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

Jiangbin Ye,Jing Fan,Sriram Venneti,Ying-Wooi Wan,Bruce R. Pawel,Ji Zhang,Lydia W.S. Finley,Chao Lu,Tullia Lindsten,Justin R. Cross,Guoliang Qing,Zhandong Liu,M. Celeste Simon,Joshua D. Rabinowitz,Craig B. Thompson

DOI: https://doi.org/10.1158/2159-8290.22530234

2023-01-01

Abstract:Knockdown of SHMT2 reduces xenograft growth in vivo.

What problem does this paper attempt to address?

Supplementary Figure 2 from Serine Catabolism Regulates Mitochondrial Redox Control During Hypoxia

Jiangbin Ye,Jing Fan,Sriram Venneti,Ying-Wooi Wan,Bruce R. Pawel,Ji Zhang,Lydia W.S. Finley,Chao Lu,Tullia Lindsten,Justin R. Cross,Guoliang Qing,Zhandong Liu,M. Celeste Simon,Joshua D. Rabinowitz,Craig B. Thompson

DOI: https://doi.org/10.1158/2159-8290.22530246

2023-01-01

Abstract:The hypoxic induction of SHMT2 depends on HIF-1alpha. SK-N-BE(2) cells stably expressing non-targeting shRNA or a shRNA against HIF-1alpha were exposed to normoxia (Nor) or 0.5% O2 (Hyp) for 8 hours. mRNA levels were measured using Q-PCR and normalized to normoxia control.
Supplementary Figure 4 from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

Jiangbin Ye,Jing Fan,Sriram Venneti,Ying-Wooi Wan,Bruce R. Pawel,Ji Zhang,Lydia W.S. Finley,Chao Lu,Tullia Lindsten,Justin R. Cross,Guoliang Qing,Zhandong Liu,M. Celeste Simon,Joshua D. Rabinowitz,Craig B. Thompson

DOI: https://doi.org/10.1158/2159-8290.22530240.v1

2023-01-01

Abstract:(A) Kelly cells stably expressing non-targeting shRNA (shNT) or SHMT2 shRNA (shSHMT2) were exposed to normoxia (Nor) or 0.5% O2 (Hyp) for 24 hours. Total cellular DNA were extracted and relative mitochondria/nuclear DNA ratio were measured using Q-PCR. (Data represent Mean {plus minus} S.D of four independent experiments). (B) Kelly cells were exposed to normoxia (Nor) or 0.5% O2 (Hyp) for 6h. ROS levels were measured using a flow cytometry-based MitoTracker Red CM-H2Ros assay. All values are normalized to normoxic shNT control cells (Data represent Mean {plus minus} S.D of three biological repeats, ***p<0.001, determined by Student's two-tailed t-test). (C) Knockdown of SHMT2 display swollen mitochondria upon hypoxic stress. Kelly cells was exposed to normoxia (Nor) or 0.5% O2 (Hyp) for 24 hours. Cells were fixed and pictures were taken under electronic microscope (EM) (25000X). Arrows indicate mitochondria.
Serine Catabolism Regulates Mitochondrial Redox Control During Hypoxia

Jiangbin Ye,Jing Fan,Sriram Venneti,Ying-Wooi Wan,Bruce R. Pawel,Ji Zhang,Lydia W. S. Finley,Chao Lu,Tullia Lindsten,Justin R. Cross,Guoliang Qing,Zhandong Liu,M. Celeste Simon,Joshua D. Rabinowitz,Craig B. Thompson

DOI: https://doi.org/10.1158/2159-8290.cd-14-0250

IF: 28.2

2014-01-01

Cancer Discovery

Abstract:Abstract The de novo synthesis of the nonessential amino acid serine is often upregulated in cancer. In this study, we demonstrate that the serine catabolic enzyme, mitochondrial serine hydroxymethyltransferase (SHMT2), is induced when MYC-transformed cells are subjected to hypoxia. In mitochondria, SHMT2 can initiate the degradation of serine to CO2 and NH4+, resulting in net production of NADPH from NADP+. Knockdown of SHMT2 in MYC-dependent cells reduced cellular NADPH:NADP+ ratio, increased cellular reactive oxygen species, and triggered hypoxia-induced cell death. In vivo, SHMT2 suppression led to impaired tumor growth. In MYC-amplified neuroblastoma patient samples, there was a significant correlation between SHMT2 and hypoxia-inducible factor-1 α (HIF1α), and SHMT2 expression correlated with unfavorable patient prognosis. Together, these data demonstrate that mitochondrial serine catabolism supports tumor growth by maintaining mitochondrial redox balance and cell survival. Significance: In this study, we demonstrate that the mitochondrial enzyme SHMT2 is induced upon hypoxic stress and is critical for maintaining NADPH production and redox balance to support tumor cell survival and growth. Cancer Discov; 4(12); 1406–17. ©2014 AACR. See related commentary by Martínez-Reyes and Chandel, p. 1371 This article is highlighted in the In This Issue feature, p. 1355
Supplementary Figure 1 from Determination of the Role of Target Tissue Metabolism in Lung Carcinogenesis Using Conditional Cytochrome <i>p</i>450 Reductase-Null Mice

Wei Yan,Cheng Fang,Robert J. Turesky,Melissa Behr,Laurence S. Kaminsky,Xinxin Ding

DOI: https://doi.org/10.1158/0008-5472.22368285.v1

2023-01-01

Abstract:Supplementary Figure 1 from Determination of the Role of Target Tissue Metabolism in Lung Carcinogenesis Using Conditional Cytochrome P450 Reductase-Null Mice
Supplementary Figures (figure S1 - S7) from SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

Xin Yang,Zhe Wang,Xin Li,Boya Liu,Minghui Liu,Lu Liu,Shuaiyi Chen,Mengmeng Ren,Yankun Wang,Miao Yu,Bo Wang,Junhua Zou,Wei-Guo Zhu,Yuxin Yin,Wei Gu,Jianyuan Luo

DOI: https://doi.org/10.1158/0008-5472.22417766.v1

2023-01-01

Abstract:Figure S1 shows the SIRT5 interaction network and SHMT2 identification. Figure S2 shows that SIRT5 is irreplaceable for cancer cell in response to serine deprivation. Figure S3 shows that SIRT5 desuccinylates SHMT2. Figure S4 shows that SIRT5 upregulates SHMT2 enzymatic activity under metabolic stress. Figure S5 shows that K280 is the major succinylation site of SHMT2. Figure S6 shows that succinylation of SHMT2 at K280 restrains cellular redox balance and clonogenic growth. Figure S7 shows that succinylation of SHMT2 at K280 impairs tumor cell growth in vivo and in vitro
Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis

Guangwei Liu,Yujing Bi,Bo Shen,Hui Yang,Yan Zhang,Xiao Wang,Huanrong Liu,Yun Lu,Jiongbo Liao,Xi Chen,Yiwei Chu

DOI: https://doi.org/10.1158/0008-5472.22401441.v1

2023-01-01

Abstract:PDF file - 436K, Fig.S1. MDSC polarizing differentiation condition alters glycolytic activity. Fig.S2.MDSC SIRT1 expansions in spleen and tumor of SIRT1KO and WT-bearing tumor mice. Fig.S3.SIRT1 deficiency MDSCs showed normal cell death and proliferation. Fig.S4.SIRT1 is required for MDSC polarization. Fig.S5.Characterization of surface marker of bone marrow-derived MDSCs. Fig.S6.SIRT1 intrinsicly controls the function and differentiation of tumor MDSCs. Fig.S7.The potentiating killing activity of SIRT1-/- MDSCs is associated with the higher glycolytic activity. Fig.S8.CD115+ monocytic MDSC effects in tumor killing. Fig.S9.SIRT1 deficiency from MDSCs could not alter the activation of NF-κB signaling after LPS treatment. Fig.S10.SIRT1-dependent MDSC glycolytic activity changes are associated with mTOR-HIF1α pathway. Fig.S11.SIRT-HIF axis directs the function and fate of MDSC associated with glycolytic activity. Fig.S12.SIRT-HIF axis potentiates glycolytic activity and tumor killing ability. Fig.S13.SIRT1 masters MDSC function and fate in tumor through mTOR/HIF1α dependent glycolytic pathway.
Elucidation of the Role of SHMT2 in L-Serine Homeostasis in Hypoxic Hepa1-6 Cells

Shuo Zhang,Ruoxu He,Mingsi Zhang,Jingcheng Zhang,Mengting Wu,Guangji Zhang,Tao Jiang

DOI: https://doi.org/10.3390/ijms252111786

IF: 5.6

2024-11-03

International Journal of Molecular Sciences

Abstract:Hypoxia is a characteristic feature of malignancy; however, its effect on metabolism remains unclear. In this study, Hepa1-6 cells were cultured under hypoxic conditions and their metabolites were analyzed. Elevated levels of L-serine along with increased glycolytic activity are prominent features of hypoxia. Transcriptome sequencing revealed the downregulation of genes involved in L-serine synthesis and metabolism, which was confirmed by PCR analysis and comparison with public databases. Further experimental evidence indicates that the accumulation of L-serine under hypoxic conditions is attributable not only to enhanced glycolysis but also to a reduction in the catabolism of L-serine mediated by serine hydroxymethyltransferase 2 (SHMT2).

biochemistry & molecular biology,chemistry, multidisciplinary
Supplemental Figure 5 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Haowen Jiang,Clifford Jiajun He,Albert M. Li,Bo He,Yang Li,Meng-Ning Zhou,Jiangbin Ye

DOI: https://doi.org/10.1158/1541-7786.23710121

2023-01-01

Abstract:S5. Mitochondrial uncoupler NEN, FCCP and BAM15 inhibit reductive carboxylation under hypoxia.
SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

Xin Yang,Zhe Wang,Xin Li,Boya Liu,Minghui Liu,Lu Liu,Shuaiyi Chen,Mengmeng Ren,Yankun Wang,Miao Yu,Bo Wang,Junhua Zou,Wei-Guo Zhu,Yuxin Yin,Wei Gu,Jianyuan Luo

DOI: https://doi.org/10.1158/0008-5472.can-17-1912

IF: 11.2

2018-01-01

Cancer Research

Abstract:AbstractThe mitochondrial serine hydroxymethyltransferase SHMT2, which catalyzes the rate-limiting step in serine catabolism, drives cancer cell proliferation, but how this role is regulated is undefined. Here, we report that the sirtuin SIRT5 desuccinylates SHMT2 to increase its activity and drive serine catabolism in tumor cells. SIRT5 interaction directly mediated desuccinylation of lysine 280 on SHMT2, which was crucial for activating its enzymatic activity. Conversely, hypersuccinylation of SHMT2 at lysine 280 was sufficient to inhibit its enzymatic activity and downregulate tumor cell growth in vitro and in vivo. Notably, SIRT5 inactivation led to SHMT2 enzymatic downregulation and to abrogated cell growth under metabolic stress. Our results reveal that SHMT2 desuccinylation is a pivotal signal in cancer cells to adapt serine metabolic processes for rapid growth, and they highlight SIRT5 as a candidate target for suppressing serine catabolism as a strategy to block tumor growth.Significance: These findings reveal a novel mechanism for controlling cancer cell proliferation by blocking serine catabolism, as a general strategy to impede tumor growth. Cancer Res; 78(2); 372–86. ©2017 AACR.
Mitochondrial serine catabolism safeguards maintenance of the hematopoietic stem cell pool in homeostasis and injury

Changhong Du,Chaonan Liu,Kuan Yu,Shuzhen Zhang,Zeyu Fu,Xinliang Chen,Weinian Liao,Jun Chen,Yimin Zhang,Xinmiao Wang,Mo Chen,Fang Chen,Mingqiang Shen,Cheng Wang,Shilei Chen,Song Wang,Junping Wang

DOI: https://doi.org/10.1016/j.stem.2024.07.009

IF: 23.9

2024-08-21

Cell Stem Cell

Abstract:Hematopoietic stem cells (HSCs) employ a very unique metabolic pattern to maintain themselves, while the spectrum of their metabolic adaptations remains incompletely understood. Here, we uncover a distinct and heterogeneous serine metabolism within HSCs and identify mouse HSCs as a serine auxotroph whose maintenance relies on exogenous serine and the ensuing mitochondrial serine catabolism driven by the hydroxymethyltransferase 2 (SHMT2)-methylene-tetrahydrofolate dehydrogenase 2 (MTHFD2) axis. Mitochondrial serine catabolism primarily feeds NAD(P)H generation to maintain redox balance and thereby diminishes ferroptosis susceptibility of HSCs. Dietary serine deficiency, or genetic or pharmacological inhibition of the SHMT2-MTHFD2 axis, increases ferroptosis susceptibility of HSCs, leading to impaired maintenance of the HSC pool. Moreover, exogenous serine protects HSCs from irradiation-induced myelosuppressive injury by fueling mitochondrial serine catabolism to mitigate ferroptosis. These findings reframe the canonical view of serine from a nonessential amino acid to an essential niche metabolite for HSC pool maintenance.
Supplemental Figure 2 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Haowen Jiang,Clifford Jiajun He,Albert M. Li,Bo He,Yang Li,Meng-Ning Zhou,Jiangbin Ye

DOI: https://doi.org/10.1158/1541-7786.24229834

2023-01-01

Abstract:S2. Mitochondrial uncoupler NEN accelerates forward TCA cycle and inhibits reductive carboxylation.
Supplemental Figure 8 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Haowen Jiang,Clifford Jiajun He,Albert M. Li,Bo He,Yang Li,Meng-Ning Zhou,Jiangbin Ye

DOI: https://doi.org/10.1158/1541-7786.24229816.v1

2023-01-01

Abstract:S8. Mitochondrial uncoupling inhibits proliferation upon anchorage-independent growth.
Supplementary Figure S5 from JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification

Wenyi Sun,Zuoquan Xie,Yifu Liu,Dan Zhao,Zhixiang Wu,Dadong Zhang,Hao Lv,Shuai Tang,Nan Jin,Hualiang Jiang,Minjia Tan,Jian Ding,Cheng Luo,Jian Li,Min Huang,Meiyu Geng

DOI: https://doi.org/10.1158/0008-5472.22410417

2023-01-01

Abstract:The variable growth dependency of different cell lines on PDK1.
SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells

Yun Zhang,Zhe Liu,Xueliang Wang,Hui Jian,Haihan Xiao,Tingyi Wen

DOI: https://doi.org/10.1038/s41417-022-00470-5

IF: 5.854

2022-04-14

Cancer Gene Therapy

Abstract:Mitochondrial serine hydroxymethyltransferase (SHMT2) catalyzes the conversion of serine to glycine and concomitantly produces one-carbon units to support cell growth and is upregulated in various cancer cells. SHMT2 knockdown triggers cell apoptosis; however, the detailed mechanism of apoptosis induced by SHMT2 inactivation remains unknown. Here, we demonstrate that SHMT2 supports the proliferation of bladder cancer (BC) cells by maintaining redox homeostasis. SHMT2 knockout decreased the pools of purine and one-carbon units and delayed cell cycle progression in a manner that was rescued by formate, demonstrating that SHMT2-mediated one-carbon units are essential for BC cell proliferation. SHMT2 deficiency promoted the accumulation of intracellular reactive oxygen species (ROS) by decreasing the NADH/NAD+, NADPH/NADP+, and GSH/GSSG ratios, leading to a loss in mitochondrial membrane potential, release of cytochrome c, translocation of Bcl-2 family protein and activation of caspase-3. Notably, blocking ROS production with the one-carbon donor formate and the ROS scavenger N-acetyl-cysteine (NAC) effectively rescued SHMT2 deficiency-induced cell apoptosis via the intrinsic signaling pathway. Treatment with the SHMT inhibitor SHIN1 resulted in a significant inhibitory effect on cell proliferation and induced cell apoptosis. Formate and NAC rescued SHIN1-induced cell apoptosis. Our findings reveal an important mechanism by which the loss of SHMT2 triggers ROS-dependent, mitochondrial-mediated apoptosis, which gives insight into the link between serine metabolism and cell apoptosis and provides a promising target for BC treatment and drug discovery.

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Multiomics analysis reveals serine catabolism as a potential therapeutic target for MELAS

Tongling Liufu,Xutong Zhao,Meng Yu,Zhiying Xie,Lingchao Meng,He Lv,Wei Zhang,Yun Yuan,Guogang Xing,Jianwen Deng,Zhaoxia Wang

DOI: https://doi.org/10.1096/fj.202302286RRR

2024-06-30

Abstract:Mitochondrial disease is a devastating genetic disorder, with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and m.3243A>G being the most common phenotype and genotype, respectively. The treatment for MELAS patients is still less effective. Here, we performed transcriptomic and proteomic analysis in muscle tissue of MELAS patients, and discovered that the expression of molecules involved in serine catabolism were significantly upregulated, and serine hydroxymethyltransferase 2 (SHMT2) increased significantly in both the mRNA and protein levels. The SHMT2 protein level was also increased in myoblasts with m.3243A>G mutation, which was transdifferentiated from patients derived fibroblasts, accompanying with the decreased nicotinamide adenine dinucleotide (NAD+)/reduced NAD+ (NADH) ratio and cell viability. After treating with SHMT2 inhibitor (SHIN1), the NAD+/NADH ratio and cell viability in MELAS myoblasts increased significantly. Taken together, our study indicates that enhanced serine catabolism plays an important role in the pathogenesis of MELAS and that SHIN1 can be a potential small molecule for the treatment of this disease.
Serine catabolism is essential to maintain mitochondrial respiration in mammalian cells

Stephanie Lucas,Guohua Chen,Siddhesh Aras,Jian Wang

DOI: https://doi.org/10.26508/lsa.201800036

IF: 5.781

2018-05-01

Life Science Alliance

Abstract:Breakdown of serine by the enzyme serine hydroxymethyltransferase (SHMT) produces glycine and one-carbon (1C) units. These serine catabolites provide important metabolic intermediates for the synthesis of nucleotides, as well as methyl groups for biosynthetic and regulatory methylation reactions. Recently, it has been shown that serine catabolism is required for efficient cellular respiration. Using CRISPR-Cas9 gene editing, we demonstrate that the mitochondrial SHMT enzyme, SHMT2, is essential to maintain cellular respiration, the main process through which mammalian cells acquire energy. We show that SHMT2 is required for the assembly of Complex I of the respiratory chain. Furthermore, supplementation of formate, a bona fide 1C donor, restores Complex I assembly in the absence of SHMT2. Thus, provision of 1C units by mitochondrial serine catabolism is critical for cellular respiration, at least in part by influencing the assembly of the respiratory apparatus.

biology
Supplementary Figure S4 from JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification

Wenyi Sun,Zuoquan Xie,Yifu Liu,Dan Zhao,Zhixiang Wu,Dadong Zhang,Hao Lv,Shuai Tang,Nan Jin,Hualiang Jiang,Minjia Tan,Jian Ding,Cheng Luo,Jian Li,Min Huang,Meiyu Geng

DOI: https://doi.org/10.1158/0008-5472.22410420

2023-01-01

Abstract:The variable abundance of PDK1 in different cell lines.
Selective translation of nuclear mitochondrial respiratory proteins reprograms succinate metabolism in AML development and chemoresistance

Guoqiang Han,Manman Cui,Pengbo Lu,Tiantian Zhang,Rong Yin,Jin Hu,Jihua Chai,Jing Wang,Kexin Gao,Weidong Liu,Shuxin Yao,Ziyan Cao,Yanbing Zheng,Wen Tian,Rongxia Guo,Min Shen,Zheming Liu,Weiming Li,Shanshan Zhao,Xiangpeng Lin,Yuhui Zhang,Kehan Song,Yan Sun,Fuling Zhou,Haojian Zhang

DOI: https://doi.org/10.1016/j.stem.2024.09.008

IF: 23.9

2024-09-26

Cell Stem Cell

Abstract:Mitochondrial adaptations dynamically reprogram cellular bioenergetics and metabolism and confer key properties for human cancers. However, the selective regulation of these mitochondrial responses remains largely elusive. Here, inspired by a genetic screening in acute myeloid leukemia (AML), we identify RAS effector RREB1 as a translational regulator and uncover a unique translation control system for nuclear-encoded mitochondrial proteins in human cancers. RREB1 deletion reduces mitochondrial activities and succinate metabolism, thereby damaging leukemia stem cell (LSC) function and AML development. Replenishing complex II subunit SDHD rectifies these deficiencies. Notably, inhibition of complex II re-sensitizes AML cells to venetoclax treatment. Mechanistically, a short RREB1 variant binds to a conserved motif in the 3' UTRs and cooperates with elongation factor eEF1A1 to enhance protein translation of nuclear-encoded mitochondrial mRNAs. Overall, our findings reveal a unique translation control mechanism for mitochondrial adaptations in AML pathogenesis and provide a potential strategy for targeting this vulnerability of LSCs.
ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury

Yankun Zhang,Yuchen Fan,Huili Hu,Xiaohui Zhang,Zehua Wang,Zhuanchang Wu,Liyuan Wang,Xiangguo Yu,Xiaojia Song,Peng Xiang,Xiaodong Zhang,Tixiao Wang,Siyu Tan,Chunyang Li,Lifen Gao,Xiaohong Liang,Shuijie Li,Nailin Li,Xuetian Yue,Chunhong Ma

DOI: https://doi.org/10.1038/s41467-023-43439-0

IF: 16.6

2023-01-01

Nature Communications

Abstract:Mitochondria dysfunction contributes to acute liver injuries, and mitochondrial regulators, such as PGC-1α and MCJ, affect liver regeneration. Therefore, identification of mitochondrial modulators may pave the way for developing therapeutic strategies. Here, ZHX2 is identified as a mitochondrial regulator during acute liver injury. ZHX2 both transcriptionally inhibits expression of several mitochondrial electron transport chain genes and decreases PGC-1α stability, leading to reduction of mitochondrial mass and OXPHOS. Loss of Zhx2 promotes liver recovery by increasing mitochondrial OXPHOS in mice with partial hepatectomy or CCl4-induced liver injury, and inhibition of PGC-1α or electron transport chain abolishes these effects. Notably, ZHX2 expression is higher in liver tissues from patients with drug-induced liver injury and is negatively correlated with mitochondrial mass marker TOM20. Delivery of shRNA targeting Zhx2 effectively protects mice from CCl4-induced liver injury. Together, our data clarify ZHX2 as a negative regulator of mitochondrial OXPHOS and a potential target for developing strategies for improving liver recovery after acute injuries.
Abstract 16262: Regulation of Mitochondria Redox State by GSH Repletion Triggers Cell Death

Huali Zhang,Pattraranee Limphong,Joel Pieper,Nader Chaar,Ivor J. Benjamin

IF: 37.8

2011-01-01

Circulation

Abstract:Intracellular redox balance is critical for the proper functioning of numerous proteins and biological processes. To control the redox environment of subcellular compartments, cells utilize two reg...

Supplementary Table 1 from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

Supplementary Figure 2 from Serine Catabolism Regulates Mitochondrial Redox Control During Hypoxia

Supplementary Figure 4 from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

Serine Catabolism Regulates Mitochondrial Redox Control During Hypoxia

Supplementary Figure 1 from Determination of the Role of Target Tissue Metabolism in Lung Carcinogenesis Using Conditional Cytochrome &lt;i&gt;p&lt;/i&gt;450 Reductase-Null Mice

Supplementary Figures (figure S1 - S7) from SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis

Elucidation of the Role of SHMT2 in L-Serine Homeostasis in Hypoxic Hepa1-6 Cells

Supplemental Figure 5 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

Mitochondrial serine catabolism safeguards maintenance of the hematopoietic stem cell pool in homeostasis and injury

Supplemental Figure 2 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Supplemental Figure 8 from Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells

Supplementary Figure S5 from JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification

SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells

Multiomics analysis reveals serine catabolism as a potential therapeutic target for MELAS

Serine catabolism is essential to maintain mitochondrial respiration in mammalian cells

Supplementary Figure S4 from JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification

Selective translation of nuclear mitochondrial respiratory proteins reprograms succinate metabolism in AML development and chemoresistance

ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury

Abstract 16262: Regulation of Mitochondria Redox State by GSH Repletion Triggers Cell Death

Supplementary Figure 1 from Determination of the Role of Target Tissue Metabolism in Lung Carcinogenesis Using Conditional Cytochrome <i>p</i>450 Reductase-Null Mice